Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 4 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 2/22/2013 1:32:17 PM : Outperform Start Price: $1.61 CBLI Score: -5.16

upward bias

Featured Broker Partners


Advertisement